This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • CRIC study: Chronic kidney disease progression after acute kidney injury

  • RAAS inhibition combinations and risk of acute kidney injury and hyperkalaemia in diabetic kidney disease

  • Longitudinal B-type natriuretic peptide monitoring and kidney failure

  • Serum potassium and risk of death or kidney replacement therapy in older patients with advanced CKD

  • Low and high potassium levels associated with harm in older people with chronic kidney disease

  • Digital physical activity and emotional well-being intervention: Kidney BEAM trial design and baseline data

  • Chronic kidney disease and incident heart failure: insights from the Atherosclerosis Risk in Communities study

  • The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

    The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

  • Apixaban vs warfarin in patients with nonvalvular atrial fibrillation receiving dialysis

    Apixaban vs warfarin in patients with nonvalvular atrial fibrillation receiving dialysis

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe